Cancer Communications
Country
United Kingdom
Western Europe
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Cancer Research
Q1
└
Oncology
Q1
Publisher
SJR 2025
7.986
Q1
SJR Score
H-Index
108
Citations / Doc (2yr)
14.38
Total Docs. (latest)
122
Total Citations (3yr)
5,166
Publication type
Journals
ISSN
25233548
Coverage
2017-2026
Journal Rank
#134
Subject Categories
Cancer Research
Q1
Oncology
Q1
Subject Areas
Aims & Scope
Cancer Communications is an open access, peer-reviewed online journal that encompasses basic, clinical, and translational cancer research.
The journal welcomes submissions concerning clinical trials, epidemiology, molecular and cellular biology, and genetics.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Web of Science
Medline
PubMed
Embase
Detailed Metrics
| Total Docs. (latest) | 122 |
| Total Docs. (3 years) | 308 |
| Total Refs. | 7,269 |
| Total Citations (3 years) | 5,166 |
| Citable Docs. (3 years) | 158 |
| Citations / Doc. (2 years) | 14.38 |
| Ref. / Doc. | 59.58 |
| % Female | 42.5% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Cancer Communications?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Cancer Communications has an SJR of 7.986 and is ranked Q1.
What is the SJR and quartile of Cancer Communications?
Cancer Communications has an SJR (SCImago Journal Rank) of 7.986 and its best quartile is Q1.
What is the H-index of Cancer Communications?
The H-index of Cancer Communications is 108, meaning 108 of its articles have each been cited at least 108 times.
Is Cancer Communications indexed in Scopus?
Yes. Cancer Communications is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.